Dr Richard Dillon Academics Clinical Senior Lecturer in Cancer Genetics Consultant Haematologist. Contact details richard.dillon@kcl.ac.uk +44 (0) 20 7188 2579
Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in Acute Promyelocytic Leukemia Dillon, R., Villiers, W., Osborne, C. & Lavender, P., 24 Jan 2023, (Accepted/In press) In: Nature Communications. Research output: Contribution to journal › Article › peer-review Unified classification and risk-stratification in Acute Myeloid Leukemia Tazi, Y., Arango-Ossa, J. E., Zhou, Y., Bernard, E., Thomas, I., Gilkes, A., Freeman, S., Pradat, Y., Johnson, S. J., Hills, R., Dillon, R., Levine, M. F., Leongamornlert, D., Butler, A., Ganser, A., Bullinger, L., Döhner, K., Ottmann, O., Adams, R., Döhner, H., & 7 othersCampbell, P. J., Burnett, A. K., Dennis, M., Russell, N. H., Devlin, S. M., Huntly, B. J. P. & Papaemmanuil, E., Dec 2022, In: Nature Communications. 13, 1, 4622. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41467-022-32103-8 Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial Dillon, R., 22 Oct 2022, (Accepted/In press) In: BMC Cancer. Research output: Contribution to journal › Article › peer-review Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype Harrington, P., Dillon, R., Radia, D., McLornan, D., Woodley, C., Asirvatham, S., Raj, K., Curto-Garcia, N., Saunders, J., Kordasti, S., Harrison, C. & de Lavallade, H., Sep 2022, In: British Journal of Haematology. 198, 6, p. 1011-1015 5 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1111/bjh.18302 Optimising care for UK patients with acute myeloid leukaemia Pagliuca, A., Khwaja, A., Dillon, R., Evans, P. A. S. & Mohite, U., 2 Aug 2022, In: British Journal of Hospital Medicine. 83, 8 Research output: Contribution to journal › Review article › peer-review. DOIs: https://doi.org/10.12968/hmed.2022.0229 Engineering of an avidity-optimized CD19-specific parallel chimeric antigen receptor that delivers dual CD28 and 4-1BB co-stimulation Halim, L., Das, K., Larcombe-Young, D., Ajina, A., Candelli, A., Benjamin, R., Dillon, R., Davies, D. & Maher, J., 9 Feb 2022, In: Frontiers in immunology. 13, 836549. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.3389/fimmu.2022.836549 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party Heuser, M., Freeman, S. D., Ossenkoppele, G. J., Buccisano, F., Hourigan, C. S., Ngai, L. L., Tettero, J. M., Bachas, C., Baer, C., Béné, M. C., Bücklein, V., Czyz, A., Denys, B., Dillon, R., Feuring-Buske, M., Guzman, M. L., Haferlach, T., Han, L., Herzig, J. K., Jorgensen, J. L., & 25 othersKern, W., Konopleva, M. Y., Lacombe, F., Libura, M., Majchrzak, A., Maurillo, L., Ofran, Y., Philippe, J., Plesa, A., Preudhomme, C., Ravandi, F., Roumier, C., Subklewe, M., Thol, F., van de Loosdrecht, A. A., van der Reijden, B. A., Venditti, A., Wierzbowska, A., Valk, P. J. M., Wood, B. L., Walter, R. B., Thiede, C., Döhner, K., Roboz, G. J. & Cloos, J., 30 Dec 2021, In: Blood. 138, 26, p. 2753-2767 15 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1182/blood.2021013626 A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia Zeidner, J. F., Lin, T. L., Vigil, C. E., Fine, G., Yair Levy, M., Nazha, A., Esteve, J., Lee, D. J., Yee, K., Dalovisio, A., Wang, E. S., Bergua Burgues, J. M., Schriber, J., Litzow, M. R., Frankfurt, O., Castillo, T. B. D., Bhatt, V. R., Bhatnagar, B., Mehta, P., Dillon, R., & 5 othersVicente, M. V., Anthony, S., Bearss, D., Montesinos, P. & Douglas Smith, B., Oct 2021, In: Blood Cancer Journal. 11, 10, 175. Research output: Contribution to journal › Letter › peer-review. DOIs: https://doi.org/10.1038/s41408-021-00568-3 Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis Dillon, R., Ahearne, M. J., Quek, L., Potter, N., Jovanovic, J., Foot, N., Valganon, M., Jayne, S., Dennis, M., Raj, K., Tauro, S., Dyer, M. J. S., Russell, N., Solomon, E. & Grimwade, D., Aug 2021, In: Leukemia. 35, 8, p. 2407-2411 5 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41375-021-01150-3 Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature Alimam, S., Villiers, W., Dillon, R., Simpson, M., Runglall, M., Smith, A., Chatzikyriakou, P., Lavender, P., Kanda, A., Mills, K., Bellosillo Paricio, B., Kaufman-Cook, J., Ord, S., Kordasti, S., Radia, D., Woodley, C., Francis, Y., Mufti, G., McLornan, D. P. & Harrison, C. N., 23 Feb 2021, In: Blood Advances. 5, 4, p. 1059-1068 10 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1182/bloodadvances.2020003172 View all publications
4 February 2021 Study investigating treatment for acute myeloid leukaemia launches at King's Five clinical trials, including a trial for blood cancer patients with acute myeloid leukaemia led…